Download Free Sample Report

The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
This report contains market size and forecasts of Minimally Invasive Treatment of Lung Cancer in Global, including the following market information:

• Global Minimally Invasive Treatment of Lung Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global top five companies in 2022 (%)

The global Minimally Invasive Treatment of Lung Cancer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Lung Tumor Ablation Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific and Smith and Nephew, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Minimally Invasive Treatment of Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Minimally Invasive Treatment of Lung Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Type, 2022 (%)

• Lung Tumor Ablation
• Lung Tumor Embolization

Global Minimally Invasive Treatment of Lung Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Application, 2022 (%)

• Hospitals
• Ambulatory Surgical Centers

Global Minimally Invasive Treatment of Lung Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Minimally Invasive Treatment of Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Minimally Invasive Treatment of Lung Cancer revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• Olympus
• LungCare
• Broncus
• Intuitive Surgica
• Auris Health
• Angiodynamics
• Boston Scientific
• Smith and Nephew
• VISON Medical
• Nanjing MICRO-TECH